Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Determine Which Dividend Etf Has The Lowest Expense Management Fee to keep more of your gains. Use this guide to pick cost-efficient ETFs.
28,053 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
Bitcoin gains momentum, rising about 6% over the past week and briefly topping $83,000 before pulling back. Traders a...
Stellantis is betting big on a single brand to lift profits in North America. This strategic move centers on Ram and ...
Fastly stock already doubled this year, leaving many investors wondering if the rally can continue. This guide breaks...
Micron Technology sits around $905 as the AI memory stock rally faces questions. Here are three reasons investors may...
A tiny AI-focused company has surged roughly 4,000% while still welcoming retail investors. Here’s what’s driving the...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
A high-profile investor move has eyes turning to a GLP-1 stock with big growth potential. Here’s what it means for ri...
A growth stock that surged to lofty heights last year has cooled in 2026, but big buyers keep stepping in as AI capac...
A top tech stock faces a likely pullback in the second half of 2026 as demand shifts and costs rise. Traders should h...
At midyear 2026, JPMorgan’s top three overweight picks show a split: one stock has cleared its upside target, while t...